Will the Grass be Greener for the Jolly Green Giant?

The End of an Era Recently, General Mills made another big splash in the food and beverage market with the leaked announcement of a potential divestiture of the Jolly Green Giant (JGG) label. Representing a large portion of General Mills’ frozen food portfolio, Jolly Green Giant accounts for approximately $700 million of the frozen division’s $1.5 billion in total sales and has become a...

Read More

An M&A Lesson from the Easter Bunny: Don’t Take Too Many “Hops”

Spring time is here and Easter is just around the corner.  The sight of an Easter Bunny around town is sure to get children excited about the basket of goodies that he’s bringing, but that same bunny reminded us about a recent project.  As we looked at the bunny’s “hopping,” we thought back to a carve-out and merger project when we were continuously faced with the question, “How many hops...

Read More

Three Steps to Improve Total Rewards Synergies during a Merger Integration

Buyers, take note of different operating models and organizational structures during the diligence phase. If the target companies produce the same product or service, but are uniquely structured, more upfront work will be needed before operational synergies can be achieved. Particularly in the area of human capital, there are three activities organizations should perform in order to realize...

Read More

Recent Healthcare Data Breaches Should Serve as a Call to Action

The trust behind the physician-patient relationship has always remained a cornerstone of patient care.  In order for a physician to make proper diagnoses and provide optimal treatment, the patient must feel comfortable providing all pertinent details about his or her condition.  The physician’s obligation to keep this information confidential is laid out in the code of medical ethics...

Read More

WAR: What is it Good For?

As it turns out – a lot, actually… For the entirety of its existence, baseball has been a ‘numbers game’. Compared to the other major professional sports, it operates within the most straightforward and easily relatable statistical universe. Our society takes comfort in the familiarity of baseball’s individual metrics: 3,000 hits; 500 home runs; a .300 batting average.…

Read More

Prioritizing People During a Carve-Out Transaction

There is no doubt that carve-out transactions are incredibly complex, particularly when it comes to separating operations and systems. While these are the “brass tacks” on the forefront of all transaction decisions, there is another critical factor that can doom a deal if it is neglected – the people. Far too often, key leadership and cultural considerations are overlooked during a carve-out...

Read More

ERP Success During an M&A Transaction – Part 2: ERP Selection

Close your eyes and take a minute to envision the future of your business. Where do you want to be next year, over the next five years, and even ten years into the future? You’ve probably spent a lot of time thinking about size, revenue, profitability and service offerings. The last thing on your mind may be the scalability of core business technology applications.…

Read More

Key ERP decisions facing Global M&A

Today many medium and small businesses are selling products in a global economy and employing a global workforce.  Many of those businesses have outsourced key functions to meet customer demands and keep costs low. Your software development team might be in Hyderabad, India, your procurement department may reside in Bratislava, Slovakia or you may be running a ‘Maquiladora’ free trade zone...

Read More

Getting Ready to Sell

You are considering selling your company – the business you’ve been nurturing for so many years. In today’s ultra competitive deal landscape with multiples at near record levels, it is important to be as prepared as possible for the sell process. Prepare your business for sale the same way you would prepare your house for sale – by taking care of red flags before you put your business (house)...

Read More

Can big pharma cure the common divestiture headache? Part 2 of 2

In part 1 of this blog, we discussed the key business processes that may pose a “headache” during big pharmaceutical divestitures. This second part of the blog will now examine similar technology roadblocks and headaches. Again, having an M&A readiness assessment and practical playbook can help alleviate these headaches while minimizing cost, time and risk during a divestiture.…

Read More
Phone: 312-602-4000
Email: marketing@westmonroepartners.com
222 W. Adams
Chicago, IL 60606
Show Buttons
Share On Facebook
Share On Twitter
Share on LinkedIn
Hide Buttons